BioSpace News Archive

BioForest

Mesa Biotech Provides Corporate Update

Company Commercializes Accula™ System in EU and U.S.and Prepares for Expansion

July 26, 2018
·
4 min read
FDA

Cepheid Receives FDA Clearance and CLIA Waiver for Xpert® Xpress Flu/RSV Test

Respiratory Infection Results in as Little as 20 Minutes

July 26, 2018
·
3 min read
Business

Alkermes Plc Reports Second Quarter 2018 Financial Results

Second Quarter Revenues Increase to $304.6 Million, Driven by License Revenues and 24% Year-Over-Year Growth of Proprietary Product Net Sales

July 26, 2018
·
34 min read
Business

Concert Pharmaceuticals to Report Second Quarter 2018 Financial Results on August 2, 2018

Concert Pharmaceuticals, Inc. announced that it will report its second quarter 2018 financial results on Thursday, August 2, 2018

July 26, 2018
·
1 min read
Drug Development

Foresee Pharmaceuticals Announces Results from a Phase 1 Clinical Study, Highlighting Promising Safety, Tolerability and Pharmacokinetic Profile of FP-045, a Potent ALDH2 Activator

Foresee Pharmaceuticals Co., Ltd. announced that it has successfully completed a Phase 1 multiple ascending dose (MAD) clinical study with FP-045

July 26, 2018
·
3 min read
Business

Baxter Reports Second-Quarter 2018 Results and Increases Earnings Outlook for Full-Year 2018

Second-quarter revenue of $2.8 billion increased 9 percent on a reported basis and 4 percent on an operational basis

July 26, 2018
·
27 min read
Shriners Hospitals for Children Researcher Reveals Important New Biology Leading to Improved Healing for Bone Fractures

Most people have broken a bone or know someone who has.

July 26, 2018
·
4 min read
Drug Development

Phase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme’s ENHANZE® Technology

Subcutaneous administration using Halozyme’s proprietary ENHANZE® drug-delivery technology in combination with chemotherapy.

July 26, 2018
·
4 min read
Business

PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2018 Financial Results

PTC Therapeutics, Inc. announced that the Company will host a webcast conference call to report its second quarter 2018 financial results and provide an update on the company’s business and outlook on Tuesday, August 7, 2018 at 4:30 p.m. (ET) after closing of the market.

July 26, 2018
·
1 min read
Bio NC

Semiconductor Research Corporation Releases $26 Million in New Research Funds

JUMP program funds 24 new research projects to amplify mission of its six innovation centers

July 26, 2018
·
2 min read